Syngulon Bacteriocins - Cost-effective antibiotic-free microbial selection to boost fermentation production
The increasing regulatory requirements to which biological agents are subjected will have a great impact on all industries that use microbial fermentation-based production. There is an expectation that in the near future, zero-tolerance will apply to antibiotics. Besides the antibiotic itself, avoidance of using antibiotic resistance genes is clearly of critical importance because their complete absence is the only way to avoid their propagation in the environment or transfer of resistance to pathogenic bacteria. Syngulon antibiotic-free selection technology is based on the use of bacteriocins, discovered in 1925 by Belgian scientist Andre Gratia, that are natural antimicrobial peptide. Syngulon Solution is a cost-effective, antibiotic-free selection innovation to boost microbial fermentation.
The information set out above, is solely for the purposes of information and the Solar Impulse Foundation does not provide any guarantee as to its authenticity, completeness or accuracy. This information does not constitute investment advice or a recommendation to buy into, transact or to enter into any agreement with any of the parties or persons mentioned above. Potential investors or interested parties are solely responsible for their investment or business decisions and for performing any due diligence required by the circumstances.